Cargando…

Correction to: ITGBL1 is a new immunomodulator that favors development of melanoma tumors by inhibiting natural killer cells cytotoxicity

Detalles Bibliográficos
Autores principales:	Cheli, Yann, Tulic, Meri K., El Hachem, Najla, Nottet, Nicolas, Jacquel, Arnaud, Gesson, Maeva, Strub, Thomas, Bille, Karine, Picard-Gauci, Alexandra, Montaudié, Henri, Beranger, Guillaume E., Passeron, Thierry, Close, Pierre, Bertolotto, Corine, Ballotti, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7839296/ https://www.ncbi.nlm.nih.gov/pubmed/33504341 http://dx.doi.org/10.1186/s12943-021-01319-5

Ejemplares similares

ITGBL1 is a new immunomodulator that favors development of melanoma tumors by inhibiting natural killer cells cytotoxicity
por: Cheli, Yann, et al.
Publicado: (2021)

Innate lymphocyte-induced CXCR3B-mediated melanocyte apoptosis is a potential initiator of T-cell autoreactivity in vitiligo
por: Tulic, Meri K., et al.
Publicado: (2019)

Pivotal role of NAMPT in the switch of melanoma cells toward an invasive and drug-resistant phenotype
por: Ohanna, Mickaël, et al.
Publicado: (2018)

Discovery of a new molecule inducing melanoma cell death: dual AMPK/MELK targeting for novel melanoma therapies
por: Jaune, Emilie, et al.
Publicado: (2021)

The complex relationship between MITF and the immune system: a Melanoma ImmunoTherapy (response) Factor?
por: Ballotti, Robert, et al.
Publicado: (2020)

FBXO32 links ubiquitination to epigenetic reprograming of melanoma cells
por: Habel, Nadia, et al.
Publicado: (2021)

The “ART” of Epigenetics in Melanoma: From histone “Alterations, to Resistance and Therapies”
por: Strub, Thomas, et al.
Publicado: (2020)

E2F1 inhibition mediates cell death of metastatic melanoma
por: Rouaud, Florian, et al.
Publicado: (2018)

CD271 is an imperfect marker for melanoma initiating cells
por: Cheli, Yann, et al.
Publicado: (2014)

Immune Checkpoints in Cancers: From Signaling to the Clinic
por: Pisibon, Céline, et al.
Publicado: (2021)

Focus on cutaneous and uveal melanoma specificities
por: Pandiani, Charlotte, et al.
Publicado: (2017)

An Update on the Role of Ubiquitination in Melanoma Development and Therapies
por: Soysouvanh, Frédéric, et al.
Publicado: (2021)

Lysine Methyltransferase NSD1 and Cancers: Any Role in Melanoma?
por: Krossa, Imène, et al.
Publicado: (2022)

Secretome from senescent melanoma engages the STAT3 pathway to favor reprogramming of naive melanoma towards a tumor-initiating cell phenotype
por: Ohanna, Mickaël, et al.
Publicado: (2013)

Evaluation of the Role of ITGBL1 in Ovarian Cancer
por: Cortez, Alexander Jorge, et al.
Publicado: (2020)

New Targeted Therapies and Immunotherapies for Locally Advanced Periocular Malignant Tumours: Towards a New ‘Eye-Sparing’ Paradigm?
por: Martel, Arnaud, et al.
Publicado: (2021)

Targeting Innate Immunity to Combat Cutaneous Stress: The Vitiligo Perspective
por: Boniface, Katia, et al.
Publicado: (2021)

Regulatory Mechanism of ITGBL1 in the Metastasis of Colorectal Cancer
por: Qi, Lu, et al.
Publicado: (2020)

The pro-tumoral function of HACE1
por: El-Hachem, Najla, et al.
Publicado: (2018)

Microphthalmia Gene Product as a Signal Transducer in cAMP-Induced Differentiation of Melanocytes
por: Bertolotto, Corine, et al.
Publicado: (1998)

SIRT1 promotes proliferation and inhibits the senescence-like phenotype in human melanoma cells
por: Ohanna, Mickaël, et al.
Publicado: (2014)

Recent advances in understanding the role of HES6 in cancers
por: Krossa, Imène, et al.
Publicado: (2022)

Oral gliadin‐protected superoxide dismutase in addition to phototherapy for treating non‐segmental vitiligo: A 24‐week prospective randomized placebo‐controlled study
por: Fontas, E., et al.
Publicado: (2021)

Increased CD271 expression by the NF-kB pathway promotes melanoma cell survival and drives acquired resistance to BRAF inhibitor vemurafenib
por: Lehraiki, Abdelali, et al.
Publicado: (2015)

ITGBL1 Predicts a Poor Prognosis and Correlates EMT Phenotype in Gastric Cancer
por: Li, Rongkun, et al.
Publicado: (2017)

Impact of topical emollient, steroids alone or combined with calcipotriol, on the immune infiltrate and clinical outcome in psoriasis
por: Heim, Marjorie, et al.
Publicado: (2022)

Endoplasmic reticulum stress mediates resistance to BCL-2 inhibitor in uveal melanoma cells
por: Bellini, Lara, et al.
Publicado: (2020)

Serum Levels of ITGBL1 as an Early Diagnostic Biomarker for Hepatocellular Carcinoma with Hepatitis B Virus Infection
por: Ye, Fei, et al.
Publicado: (2021)

Baseline and early functional immune response is associated with subsequent clinical outcomes of PD-1 inhibition therapy in metastatic melanoma patients
por: Gérard, Alexandre, et al.
Publicado: (2021)

ITGBL1 promotes EMT, invasion and migration by activating NF-κB signaling pathway in prostate cancer
por: Li, Wenze, et al.
Publicado: (2019)

ITGBL1 promotes cell migration and invasion through stimulating the TGF‐β signalling pathway in hepatocellular carcinoma
por: Huang, Wei, et al.
Publicado: (2020)

Comparison of Two Rapid Assays for the Detection of BRAF V600 Mutations in Metastatic Melanoma including Positive Sentinel Lymph Nodes
por: Long-Mira, Elodie, et al.
Publicado: (2022)

Association of TRF2 expression and myeloid-derived suppressor cells infiltration with clinical outcome of patients with cutaneous melanoma
por: Ilié, Marius, et al.
Publicado: (2021)

Hypoxia-inducible factor 1α is a new target of microphthalmia-associated transcription factor (MITF) in melanoma cells
por: Buscà, Roser, et al.
Publicado: (2005)

ITGBL1 transcriptionally inhibited by JDP2 promotes the development of pancreatic cancer through the TGF-beta/Smad pathway
por: Du, Tiancong, et al.
Publicado: (2022)

New insights into the pathophysiology of the small airways in asthma
por: Hamid, Qutayba, et al.
Publicado: (2007)

Ceramide AD™ Restores Skin Integrity and Function following Exposure to House Dust Mite
por: Bzioueche, Hanene, et al.
Publicado: (2023)

Characterization of gene expression profiles in HBV-related liver fibrosis patients and identification of ITGBL1 as a key regulator of fibrogenesis
por: Wang, Mingjie, et al.
Publicado: (2017)

A comprehensive analysis of potential gastric cancer prognostic biomarker ITGBL1 associated with immune infiltration and epithelial–mesenchymal transition
por: Wang, Zhe, et al.
Publicado: (2022)

Primary tumors release ITGBL1-rich extracellular vesicles to promote distal metastatic tumor growth through fibroblast-niche formation
por: Ji, Qing, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_p0hlhb05rb7rc37d3qq4gr8393